Nagane, M., Sasaki, N., Kobayashi, K., Saito, K., Shimada, D., Matsumoto, Y., . . . Shiokawa, Y. (2020). ML-02 Chemotherapy for patients with relapsed or refractory primary CNS lymphoma. Neurooncol Adv.
Chicago Style aipamenaNagane, Motoo, et al. "ML-02 Chemotherapy for Patients With Relapsed or Refractory Primary CNS Lymphoma." Neurooncol Adv 2020.
MLA aipamenaNagane, Motoo, et al. "ML-02 Chemotherapy for Patients With Relapsed or Refractory Primary CNS Lymphoma." Neurooncol Adv 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.